Abstract:Fluctuating transcription factor (TF) networks are commonly assumed to be responsible for stochastic hematopoietic lineage choice. The PU.1 and Gata1 TF pair, driving granulocytic-monocytic (GM) versus megakaryocytic-erythroid (MegE) lineage choice, respectively, is the paradigmatic TF pair underlying this hypothesis. Lineage priming, reprogramming experiments, positive autoregulation and mutual cross-antagonism of PU.1 and Gata1 have led to the hypothesis that random ‘noisy' fluctuations in PU.1 and Gata1 expression will allow one factor ‘winning' over the other and thus to inducing lineage choice. However, this hypothesis is based on limited expression data. So far, TF expression mostly was measured at the mRNA level in discontinuous snapshot analysis. For a comprehensive understanding, quantification of protein levels before, during and after lineage choice would be required. We therefore developed novel knock-in mouse lines simultaneously expressing PU.1eYFP and Gata1mCHERRY fusion proteins from their endogenous genomic loci. FACS analysis of those phenotypically normal mice allows identification and prospective isolation of several new myeloid hematopoietic subpopulations. Long-term single cell tracking and the development of novel software tools enables us to estimate endogenous molecule numbers and to quantify TF expression kinetics and dynamics with high resolution. This approach provides the quantitative continuous data in living hematopoietic stem and progenitors cells required for testing the above mentioned hypothesis. It demonstrates that fluctuating PU.1 and Gata1 levels are not responsible for GM-MegE lineage decision making. Fluctuating transcription factor (TF) networks are commonly assumed to be responsible for stochastic hematopoietic lineage choice. The PU.1 and Gata1 TF pair, driving granulocytic-monocytic (GM) versus megakaryocytic-erythroid (MegE) lineage choice, respectively, is the paradigmatic TF pair underlying this hypothesis. Lineage priming, reprogramming experiments, positive autoregulation and mutual cross-antagonism of PU.1 and Gata1 have led to the hypothesis that random ‘noisy' fluctuations in PU.1 and Gata1 expression will allow one factor ‘winning' over the other and thus to inducing lineage choice. However, this hypothesis is based on limited expression data. So far, TF expression mostly was measured at the mRNA level in discontinuous snapshot analysis. For a comprehensive understanding, quantification of protein levels before, during and after lineage choice would be required. We therefore developed novel knock-in mouse lines simultaneously expressing PU.1eYFP and Gata1mCHERRY fusion proteins from their endogenous genomic loci. FACS analysis of those phenotypically normal mice allows identification and prospective isolation of several new myeloid hematopoietic subpopulations. Long-term single cell tracking and the development of novel software tools enables us to estimate endogenous molecule numbers and to quantify TF expression kinetics and dynamics with high resolution. This approach provides the quantitative continuous data in living hematopoietic stem and progenitors cells required for testing the above mentioned hypothesis. It demonstrates that fluctuating PU.1 and Gata1 levels are not responsible for GM-MegE lineage decision making.

A timed epigenetic switch balances T and ILC lineage proportions in the thymus

Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity

Transcription factors TCF-1 and GATA3 are key factors for the epigenetic priming of early innate lymphoid progenitors toward distinct cell fates

Single-cell deletion analyses show control of pro-T cell developmental speed and pathways by Tcf7, Spi1, Gata3, Bcl11a, Erg, and Bcl11b

Lineage Marker Synchrony in Hematopoietic Genealogies Refutes the PU.1/GATA1 Toggle Switch Paradigm

Myeloid Lineage Choice is Not Controlled by the Pu.1-Gata1 Switch

The transcription factor TCF-1 enforces commitment to the innate lymphoid cell lineage

Transcriptional Regulation of Early T-Lymphocyte Development in Thymus

Dynamic regulation of innate lymphoid cell development during ontogeny

Transcriptional Regulatory Logic Orchestrating Lymphoid and Myeloid Cell Fate Decisions

The Imprinted Dlk1-Gtl2 Locus Epigenetically Regulates Primitive Hematopoietic Stem Cell Mitochondrial Function and Energy Metabolism Via Repression of Pi3k/Akt/Mtor Pathway

Transcriptional regulators dictate innate lymphoid cell fates

Distinct Regulatory Machineries Underlying Divergent Chromatin Landscapes Distinguish Innate Lymphoid Cells from T Helper Cells

Lineage regulators TFAP2C and NR5A2 function as bipotency activators in totipotent embryos

Reversible, tunable epigenetic silencing of TCF1 generates flexibility in the T cell memory decision

An Enriched Network Motif Family Regulates Multistep Cell Fate Transitions with Restricted Reversibility

Alternative Enhancer Usage and Targeted Polycomb Marking Hallmark Promoter Choice during T Cell Differentiation

Synergistic and antagonistic activities of IRF8 and FOS enhancer pairs during an immune cell fate switch

Reciprocal transcription factor networks govern tissue-resident ILC3 subset function and identity

Zinc finger protein Zfp335 controls early T cell development and survival through β-selection-dependent and -independent mechanisms

Histone Methylation Mediates Plasticity of Human Foxp3+ Regulatory T Cells by Modulating Signature Gene Expressions